Table 1. The clinical characters of the cervical cancer group.
| Case number | Age | FIGO stage | Pathology type | Degree of histological differentiation | HPV test |
|---|---|---|---|---|---|
| C1 | 47 | Ib1 | SCC | Well | HPV16 |
| C2 | 61 | IIa | ASC | Poor | HPV16,18 |
| C3 | 29 | IIb | SCC | Well | HPV16,18 |
| C4 | 54 | Ib1 | SCC | Well | HPV16 |
| C5 | 51 | IIb | ASC | Poor | HPV16,45 |
| C6 | 54 | Ib1 | SCC | Well | HPV16 |
| C7 | 39 | Ib2 | SCC | Poor | HPV16 |
| C8 | 35 | Ib2 | SCC | Well | HPV16 |
| C9 | 49 | Ib1 | AC (EC) | Moderate | Negative |
| C10 | 34 | Ib1 | SCC | Poor | HPV16 |
| C11 | 53 | IIIb | SCC | Well | HPV16,18 |
| C12 | 38 | Ib1 | SCC | Well | HPV16 |
| C13 | 23 | Ib1 | SCC | Well | HPV16 |
| C14 | 47 | IIb | SCC | Moderate | HPV16 |
| C15 | 44 | Ia1 | SCC | Poor | HPV16,52 |
| C 16 | 61 | Ib2 | SCC | Poor | HPV16 |
| C17 | 48 | Ib2 | AC | Moderate | HPV18 |
| C18 | 59 | Ib1 | AC (CCC) | Poor | Negative |
| C19 | 31 | Ib2 | SC | Well | HPV16 |
| C20 | 48 | Ib1 | SC | Poor | Negative |
| C21 | 67 | Ib1 | AC | Moderate | HPV16 |
| C22 | 54 | Ib1 | SC | Well | HPV16 |
| C23 | 55 | Ib2 | SC | Poor | HPV16,58 |
| C24 | 32 | Ib2 | CS | Poor | HPV18 |
| C25 | 53 | Ib1 | SC | Moderate | HPV16 |
| C26 | 39 | Ib1 | SC | Moderate | HPV16 |
| C27 | 44 | Ib2 | SC | Moderate | HPV16 |
ASC, adenosquamous carcinoma; AC, adenocarcinoma; CCC, clear cell carcinoma; CS, carcinosarcoma; EC, endometrioid carcinoma; FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus; SCC, squamous cell carcinoma.